A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice?

Bibliographic Details
Title: A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice?
Authors: Araújo, Fernando Antônio Glasner da Rocha, Sumita, Nairo Massakazu, Barroso Jr., Ubirajara de Oliveira
Source: International braz j urol. June 2019 45(3)
Publisher Information: Sociedade Brasileira de Urologia, 2019.
Publication Year: 2019
Subject Terms: Prostatic Neoplasms, Prostate-Specific Antigen, Mass Screening
More Details: Purpose: To evaluate the trend of use of Prostate Specific Antigen (PSA) for screening of prostate cancer (PC) among Brazilian doctors, from the beginning of its regular availability in clinical laboratories. Material and Methods: A serial cross-sectional study was performed using data obtained from a large database between 1997 and 2016. The general PSA screening trend during this period, adjusted for the total number of exams performed in men, was analyzed. Time-series analysis was performed through observation of the general regression curve using the generalized least squares method, and the impact of the recommendations was assessed with autoregressive integrated moving average (ARIMA) models. Results: During the period studied 2,521,383 PSA determinations were done. The age of the participants ranged from 21 to 111 years, with an average of 56.7 ± 22.7 years. The relative number of PSA tests/100.000 exams in males showed a constant reduction since 2001, and this trend was more evident in the group aged 55-69 years. Although statistically significant, the impact of reduced PSA screening after the 2012 USPSTF publication was clinically irrelevant. Conclusions: Our results indicated a continuous reduction in the use of PSA screening over time, regardless of the publication of recommendations or clinical guidelines. The fact that this trend was more pronounced among those with a greater benefit potential (55-69 years), relative to groups with a greater damage potential due to overdiagnosis and overtreatment (aged >74 years and <40 years), is a matter of concern. Follow-up studies of these trends are advisable.
Document Type: article
File Description: text/html
Language: English
ISSN: 1677-5538
DOI: 10.1590/s1677-5538.ibju.2018.0179
Access URL: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000300478
Rights: info:eu-repo/semantics/openAccess
Accession Number: edssci.S1677.55382019000300478
Database: SciELO
FullText Text:
  Availability: 0
CustomLinks:
  – Url: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000300478#
    Name: EDS - SciELO
    Category: fullText
    Text: Full Text from SciELO
    MouseOverText: Full Text from SciELO
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edssci&genre=article&issn=16775538&ISBN=&volume=45&issue=3&date=20190601&spage=&pages=&title=International braz j urol&atitle=A%20continuous%20fall%20of%20PSA%20use%20for%20prostate%20cancer%20screening%20among%20Brazilian%20doctors%20since%202001.%20Good%20or%20bad%20notice%3F&aulast=Ara%C3%BAjo%2C%20Fernando%20Ant%C3%B4nio%20Glasner%20da%20Rocha&id=DOI:10.1590/s1677-5538.ibju.2018.0179
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: edssci
DbLabel: SciELO
An: edssci.S1677.55382019000300478
RelevancyScore: 934
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 933.754455566406
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice?
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Ara&#250;jo%2C+Fernando+Ant&#244;nio+Glasner+da+Rocha%22&quot;&gt;Ara&#250;jo, Fernando Ant&#244;nio Glasner da Rocha&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Sumita%2C+Nairo+Massakazu%22&quot;&gt;Sumita, Nairo Massakazu&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Barroso+Jr%2E%2C+Ubirajara+de+Oliveira%22&quot;&gt;Barroso Jr., Ubirajara de Oliveira&lt;/searchLink&gt;
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;i&gt;International braz j urol&lt;/i&gt;. June 2019 45(3)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Sociedade Brasileira de Urologia, 2019.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2019
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Prostatic+Neoplasms%22&quot;&gt;Prostatic Neoplasms&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Prostate-Specific+Antigen%22&quot;&gt;Prostate-Specific Antigen&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Mass+Screening%22&quot;&gt;Mass Screening&lt;/searchLink&gt;
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Purpose: To evaluate the trend of use of Prostate Specific Antigen (PSA) for screening of prostate cancer (PC) among Brazilian doctors, from the beginning of its regular availability in clinical laboratories. Material and Methods: A serial cross-sectional study was performed using data obtained from a large database between 1997 and 2016. The general PSA screening trend during this period, adjusted for the total number of exams performed in men, was analyzed. Time-series analysis was performed through observation of the general regression curve using the generalized least squares method, and the impact of the recommendations was assessed with autoregressive integrated moving average (ARIMA) models. Results: During the period studied 2,521,383 PSA determinations were done. The age of the participants ranged from 21 to 111 years, with an average of 56.7 &#177; 22.7 years. The relative number of PSA tests/100.000 exams in males showed a constant reduction since 2001, and this trend was more evident in the group aged 55-69 years. Although statistically significant, the impact of reduced PSA screening after the 2012 USPSTF publication was clinically irrelevant. Conclusions: Our results indicated a continuous reduction in the use of PSA screening over time, regardless of the publication of recommendations or clinical guidelines. The fact that this trend was more pronounced among those with a greater benefit potential (55-69 years), relative to groups with a greater damage potential due to overdiagnosis and overtreatment (aged &gt;74 years and &lt;40 years), is a matter of concern. Follow-up studies of these trends are advisable.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: text/html
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 1677-5538
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1590/s1677-5538.ibju.2018.0179
– Name: URL
  Label: Access URL
  Group: URL
  Data: &lt;link linkTarget=&quot;URL&quot; linkTerm=&quot;http://old.scielo.br/scielo.php?script=sci_arttext&amp;pid=S1677-55382019000300478&quot; linkWindow=&quot;_blank&quot;&gt;http://old.scielo.br/scielo.php?script=sci_arttext&amp;pid=S1677-55382019000300478&lt;/link&gt;
– Name: Copyright
  Label: Rights
  Group: Cpyrght
  Data: info:eu-repo/semantics/openAccess
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edssci.S1677.55382019000300478
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edssci&AN=edssci.S1677.55382019000300478
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1590/s1677-5538.ibju.2018.0179
    Languages:
      – Text: English
    Subjects:
      – SubjectFull: Prostatic Neoplasms
        Type: general
      – SubjectFull: Prostate-Specific Antigen
        Type: general
      – SubjectFull: Mass Screening
        Type: general
    Titles:
      – TitleFull: A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Araújo, Fernando Antônio Glasner da Rocha
      – PersonEntity:
          Name:
            NameFull: Sumita, Nairo Massakazu
      – PersonEntity:
          Name:
            NameFull: Barroso Jr., Ubirajara de Oliveira
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 16775538
          Numbering:
            – Type: volume
              Value: 45
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: International braz j urol
              Type: main
ResultId 1